Search

everythinglearnresearchcommunity

for

Search:↓

Almost 40% of older men in the study had hair loss on the front and side of their legs, and most were unaware of it.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Certain drugs that block specific enzymes can help treat prostate diseases.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Early hair loss may indicate prostate issues.

Ganoderma lucidum may help treat enlarged prostate in rats.